The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder.

• Status: Completed
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

CP-866,087 is a non-hormonal compound, acting on the central nervous system, which has been shown in animal models to restore sexual function.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer

Criteria

Inclusion Criteria:

• healthy pre-menopausal women

• primary female sexual arousal disorder causing distress

• on stable use of oral contraceptives

Exclusion Criteria:

• any other significant disease causing Female Sexual Dysfunction including psychiatric disease

• subjects on drugs known to cause Female Sexual Dysfunction

• subjects who have given birth in the last 12 months or who are planning to become pregnant during the study